id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-1929-0001,FDA,FDA-2018-N-1929,Medical Devices; Immunology and Microbiology Devices; Classification of the Next Generation Sequencing Based Tumor Profiling Test,Rule,Final Rule,2018-06-22T04:00:00Z,2018,6,2018-06-22T04:00:00Z,,2018-06-22T13:01:22Z,2018-13406,0,0,0900006483442b47